Skip to main content
. 2022 Dec 31;27(4):265–272. doi: 10.6065/apem.2244166.083

Fig. 2.

Fig. 2.

The revised Cochrane risk-of-bias tool was used to quantitatively evaluate each included clinical trial.8) Most were found to have low to intermediate risk of bias.